Corneal Allograft for Near Vision Improvement in Emmetropic Presbyopia: 4-Year Safety and Efficacy Results From a Prospective European Multicenter Clinical Trial
Implantation of a sterile allograft stromal inlay in the non-dominant eyes of patients with emmetropic presbyopia was safe and effective in improving near and intermediate vision while maintaining distance vision up to 4 years after surgery.
Authors
- Michael Mrochen
- Marine Gobbé
- Samer Hamada
- Aylin Kilic
- Pavel Stodulka
- Sheraz Daya
- Arthur Cummings
- David Muller
Institutions
- Charles University (CZ)
- Queen Victoria Hospital (GB)
- Istanbul Medipol University (TR)
- London Eye Hospital (GB)
- Queen Victoria Hospital NHS Foundation Trust (GB)
- Gemini Eye Clinic (CZ)
- Atotech (United States) (US)
Publication Details
- Journal
- Journal of Refractive Surgery
- Published
- 2026-02-01
- DOI
- https://doi.org/10.3928/1081597x-20251202-02
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00